Grove Inc
Drug Manufacturers-Specialty & Generic
Healthcare
GRVI
17.82 M shares
NASDAQ US
traded
18 Aug 2022
listed
yes
open
4.60
52 week high
7.64
high
4.99
52 week low
3.90
low
4.59
growth
-5.35 %
previous Close
4.60
P/E ratio
market cap
89.96 M
div yield
0
usd
Mar 2022
qoq
revenue
10.27 M
-3.70 %
net incoming
-52.67 K
-181.23 %
eps
0.00 %
0.00 %
eps surprise
0.00 %
net profit margin
-0.51 %
-1.00 %
operating incoming
-60.50 K
-151.44 %
net change in cash
-2.09 M
67.49 %
cash on hand
4.50 M
-31.73 %
cost of revenue
4.18 M
5.77 %
top top